1. Home
  2. >Providers
  3. >Targeted Analyses
Skip to main content

Targeted analyses

Evaluate specific predefined genetic variants to determine your patient’s risk for known conditions and enable focused, personalized interventions.

Sequence Once, Query Often®

Existing Patient (SOQO)®

≤ 5 days

New Patient

6-21 days

Sample

Saliva, Blood, Buccal

One comprehensive test provides clinical answers today and enables future queries as science evolves. If your patient has been sequenced before, Helix will automatically flag them as an existing patient in your EHR ordering workflow. No new sample required.

Clinical Utility

Identifies individuals with specific genetic variants who may benefit from:

  • Focused evaluation for known genetic variants
  • Personalized care and medical management
  • Targeted monitoring or treatment options
  • Clarification of genetic risk for family members

Tech Specs

Methodology

Exome+® NGS (exome capture + deep intronic coverage in key regions + relevant promoters and inversions).

Accuracy

> 99.9% analytical sensitivity for SNVs and small indels.

CNV Resolution

Single exon-level resolution for deletions and duplications.

Wayfinder™ Interpretation

Automated pathogenicity score recommendations powered by AI intelligence, augmented by > 850k longitudinal records.

Ready to get started?

Connect with our team to learn how Helix can transform your practice with comprehensive genomic testing.